Uses
Empagliflozin works by inhibiting the sodium-glucose co-transporter-2 (SGLT-2) found in the proximal tubules in the kidneys. Through SGLT-2 inhibition, empagliflozin reduces renal reabsorption of glucose and increases urinary excretion of glucose.
INDICATIONS
Lower blood sugar along with diet and exercise in adults and children who are 10 years of age and older with type-2 diabetes.
Reduce the risk of cardiovascular death in adults with type-2 diabetes who also have known cardiovascular disease. levels.